Uterine Fibroids Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032
- Report ID: ME_0084292
- Format: Electronic (PDF)
- Publish Type:
- Number of Pages: 250
Market Snapshot
CAGR:8.48
Source: Market Expertz
| Study Period | 2019-2032 |
| Base Year | 2023 |
| Forcast Year | 2023-2032 |
| CAGR | 8.48 |
Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries
Download Sample PdfReport Overview
Uterine fibroids (myoma) are benign (non-cancerous) lumps that grow in the muscular wall of the uterus. They vary in sizes, from minute (a quarter of an inch) to the size of more than16 centimeters. The incidence of uterine fibroid is about 20%-40% in women during their reproductive ages. Occasionally, these fibroids swell up and make the uterus to grow like full visible pregnancy. Mostly, there are more than one fibroid in the uterus. However, fibroids do not always cause any symptoms, their location, and size results to difficulties for few women, including pain, discomfort and heavy bleeding. Uterine fibroid can be of different types such as intramural fibroids, subserosal fibroids, pedunculated fibroids and submucosal fibroids. There can be many reasons for uterine fibroid formation but genetic problems hormonal imbalance and other factors are predominant. The cardinal symptoms of uterine fibroids are heavy menstrual bleeding, abdominal pain, excessive uterine bleeding, increased urinary frequency, anaemia and infertility. Apart from physical morbidity, uterine fibroid ailment is a frequent cause of significant damage of quality of life and a major reason for hysterectomy. Therapy has traditionally based on two extremes: medicinal management, comprising progestins, oral contraceptives and GnRH agonists and surgical management, including myomectomy, hysterectomy, and ablation for most serious cases.Patients suffering from uterine fibroid problem represent an undeserved and huge market due to the absence of satisfactory medical treatments. Uterine fibroids affects nearly 40% of women in the age group of 30 and 55, including 20 million women in North America and 24 million women in Europe with over 7 million patients worldwide presently undergo various symptom management treatments.
In 2018, the global Uterine Fibroids market size was xx million US$ and it is expected to reach xx million US$ by the end of 2026, with a CAGR of xx% during 2019-2026.
This report focuses on the global Uterine Fibroids status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Uterine Fibroids development in United States, Europe and China.
The key players covered in this study
Boston Scientific
Cooper Surgical
C.R. Bard
F. Hoffmann-La Roche
GE Healthcare
Karl Storz Endoscopy
Richard Wolf Medical Instruments
Siemens Medical Solutions
AbbVie
AstraZeneca
Bayer
Eli Lilly
GlaxoSmithKline Pharmaceuticals
Pfizer
Johnson & Johnson
Novartis
Market segment by Type, the product can be split into
Non-Hormonal Treatment
Hormonal Treatment
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Uterine Fibroids status, future forecast, growth opportunity, key market and key players.
To present the Uterine Fibroids development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Uterine Fibroids are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Uterine Fibroids Market Size Growth Rate by Type (2014-2025)
1.4.2 Non-Hormonal Treatment
1.4.3 Hormonal Treatment
1.5 Market by Application
1.5.1 Global Uterine Fibroids Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Diagnostic Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Uterine Fibroids Market Size
2.2 Uterine Fibroids Growth Trends by Regions
2.2.1 Uterine Fibroids Market Size by Regions (2014-2025)
2.2.2 Uterine Fibroids Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Uterine Fibroids Market Size by Manufacturers
3.1.1 Global Uterine Fibroids Revenue by Manufacturers (2014-2019)
3.1.2 Global Uterine Fibroids Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Uterine Fibroids Market Concentration Ratio (CR5 and HHI)
3.2 Uterine Fibroids Key Players Head office and Area Served
3.3 Key Players Uterine Fibroids Product/Solution/Service
3.4 Date of Enter into Uterine Fibroids Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Uterine Fibroids Market Size by Type (2014-2019)
4.2 Global Uterine Fibroids Market Size by Application (2014-2019)
5 United States
5.1 United States Uterine Fibroids Market Size (2014-2019)
5.2 Uterine Fibroids Key Players in United States
5.3 United States Uterine Fibroids Market Size by Type
5.4 United States Uterine Fibroids Market Size by Application
6 Europe
6.1 Europe Uterine Fibroids Market Size (2014-2019)
6.2 Uterine Fibroids Key Players in Europe
6.3 Europe Uterine Fibroids Market Size by Type
6.4 Europe Uterine Fibroids Market Size by Application
7 China
7.1 China Uterine Fibroids Market Size (2014-2019)
7.2 Uterine Fibroids Key Players in China
7.3 China Uterine Fibroids Market Size by Type
7.4 China Uterine Fibroids Market Size by Application
8 Japan
8.1 Japan Uterine Fibroids Market Size (2014-2019)
8.2 Uterine Fibroids Key Players in Japan
8.3 Japan Uterine Fibroids Market Size by Type
8.4 Japan Uterine Fibroids Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Uterine Fibroids Market Size (2014-2019)
9.2 Uterine Fibroids Key Players in Southeast Asia
9.3 Southeast Asia Uterine Fibroids Market Size by Type
9.4 Southeast Asia Uterine Fibroids Market Size by Application
10 India
10.1 India Uterine Fibroids Market Size (2014-2019)
10.2 Uterine Fibroids Key Players in India
10.3 India Uterine Fibroids Market Size by Type
10.4 India Uterine Fibroids Market Size by Application
11 Central & South America
11.1 Central & South America Uterine Fibroids Market Size (2014-2019)
11.2 Uterine Fibroids Key Players in Central & South America
11.3 Central & South America Uterine Fibroids Market Size by Type
11.4 Central & South America Uterine Fibroids Market Size by Application
12 International Players Profiles
12.1 Boston Scientific
12.1.1 Boston Scientific Company Details
12.1.2 Company Description and Business Overview
12.1.3 Uterine Fibroids Introduction
12.1.4 Boston Scientific Revenue in Uterine Fibroids Business (2014-2019)
12.1.5 Boston Scientific Recent Development
12.2 Cooper Surgical
12.2.1 Cooper Surgical Company Details
12.2.2 Company Description and Business Overview
12.2.3 Uterine Fibroids Introduction
12.2.4 Cooper Surgical Revenue in Uterine Fibroids Business (2014-2019)
12.2.5 Cooper Surgical Recent Development
12.3 C.R. Bard
12.3.1 C.R. Bard Company Details
12.3.2 Company Description and Business Overview
12.3.3 Uterine Fibroids Introduction
12.3.4 C.R. Bard Revenue in Uterine Fibroids Business (2014-2019)
12.3.5 C.R. Bard Recent Development
12.4 F. Hoffmann-La Roche
12.4.1 F. Hoffmann-La Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Uterine Fibroids Introduction
12.4.4 F. Hoffmann-La Roche Revenue in Uterine Fibroids Business (2014-2019)
12.4.5 F. Hoffmann-La Roche Recent Development
12.5 GE Healthcare
12.5.1 GE Healthcare Company Details
12.5.2 Company Description and Business Overview
12.5.3 Uterine Fibroids Introduction
12.5.4 GE Healthcare Revenue in Uterine Fibroids Business (2014-2019)
12.5.5 GE Healthcare Recent Development
12.6 Karl Storz Endoscopy
12.6.1 Karl Storz Endoscopy Company Details
12.6.2 Company Description and Business Overview
12.6.3 Uterine Fibroids Introduction
12.6.4 Karl Storz Endoscopy Revenue in Uterine Fibroids Business (2014-2019)
12.6.5 Karl Storz Endoscopy Recent Development
12.7 Richard Wolf Medical Instruments
12.7.1 Richard Wolf Medical Instruments Company Details
12.7.2 Company Description and Business Overview
12.7.3 Uterine Fibroids Introduction
12.7.4 Richard Wolf Medical Instruments Revenue in Uterine Fibroids Business (2014-2019)
12.7.5 Richard Wolf Medical Instruments Recent Development
12.8 Siemens Medical Solutions
12.8.1 Siemens Medical Solutions Company Details
12.8.2 Company Description and Business Overview
12.8.3 Uterine Fibroids Introduction
12.8.4 Siemens Medical Solutions Revenue in Uterine Fibroids Business (2014-2019)
12.8.5 Siemens Medical Solutions Recent Development
12.9 AbbVie
12.9.1 AbbVie Company Details
12.9.2 Company Description and Business Overview
12.9.3 Uterine Fibroids Introduction
12.9.4 AbbVie Revenue in Uterine Fibroids Business (2014-2019)
12.9.5 AbbVie Recent Development
12.10 AstraZeneca
12.10.1 AstraZeneca Company Details
12.10.2 Company Description and Business Overview
12.10.3 Uterine Fibroids Introduction
12.10.4 AstraZeneca Revenue in Uterine Fibroids Business (2014-2019)
12.10.5 AstraZeneca Recent Development
12.11 Bayer
12.12 Eli Lilly
12.13 GlaxoSmithKline Pharmaceuticals
12.14 Pfizer
12.15 Johnson & Johnson
12.16 Novartis
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Uterine Fibroids Key Market Segments
Table Key Players Uterine Fibroids Covered
Table Global Uterine Fibroids Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Uterine Fibroids Market Size Market Share by Type 2014-2025
Figure Non-Hormonal Treatment Figures
Table Key Players of Non-Hormonal Treatment
Figure Hormonal Treatment Figures
Table Key Players of Hormonal Treatment
Table Global Uterine Fibroids Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Diagnostic Centers Case Studies
Figure Others Case Studies
Figure Uterine Fibroids Report Years Considered
Table Global Uterine Fibroids Market Size 2014-2025 (Million US$)
Figure Global Uterine Fibroids Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Uterine Fibroids Market Size by Regions 2014-2025 (Million US$)
Table Global Uterine Fibroids Market Size by Regions 2014-2019 (Million US$)
Table Global Uterine Fibroids Market Share by Regions 2014-2019
Figure Global Uterine Fibroids Market Share by Regions 2014-2019
Figure Global Uterine Fibroids Market Share by Regions 2019
Table Market Top Trends
Table Global Uterine Fibroids Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Uterine Fibroids Market Share by Manufacturers (2014-2019)
Figure Global Uterine Fibroids Market Share by Manufacturers in 2018
Table Global Uterine Fibroids Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Uterine Fibroids Product/Solution/Service
Table Date of Enter into Uterine Fibroids Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Uterine Fibroids Market Size by Type (2014-2019) (Million US$)
Table Global Uterine Fibroids Market Size Share by Type (2014-2019)
Figure Global Uterine Fibroids Market Size Market Share by Type (2014-2019)
Table Global Uterine Fibroids Market Size by Application (2014-2019) (Million US$)
Table Global Uterine Fibroids Market Size Share by Application (2014-2019)
Figure Global Uterine Fibroids Market Size Market Share by Application (2014-2019)
Figure Global Uterine Fibroids Revenue Market Share by Application in 2018
Figure United States Uterine Fibroids Market Size 2014-2019 (Million US$)
Table United States Key Players Uterine Fibroids Revenue (2018-2019) (Million US$)
Table United States Key Players Uterine Fibroids Market Share (2018-2019)
Table United States Uterine Fibroids Market Size by Type (2014-2019) (Million US$)
Table United States Uterine Fibroids Market Share by Type (2014-2019)
Table United States Uterine Fibroids Market Size by Application (2014-2019) (Million US$)
Table United States Uterine Fibroids Market Share by Application (2014-2019)
Figure Europe Uterine Fibroids Market Size 2014-2019 (Million US$)
Table Europe Key Players Uterine Fibroids Revenue (2018-2019) (Million US$)
Table Europe Key Players Uterine Fibroids Market Share (2018-2019)
Table Europe Uterine Fibroids Market Size by Type (2014-2019) (Million US$)
Table Europe Uterine Fibroids Market Share by Type (2014-2019)
Table Europe Uterine Fibroids Market Size by Application (2014-2019) (Million US$)
Table Europe Uterine Fibroids Market Share by Application (2014-2019)
Figure China Uterine Fibroids Market Size 2014-2019 (Million US$)
Table China Key Players Uterine Fibroids Revenue (2018-2019) (Million US$)
Table China Key Players Uterine Fibroids Market Share (2018-2019)
Table China Uterine Fibroids Market Size by Type (2014-20189) (Million US$)
Table China Uterine Fibroids Market Share by Type (2014-2019)
Table China Uterine Fibroids Market Size by Application (2014-2019) (Million US$)
Table China Uterine Fibroids Market Share by Application (2014-2019)
Figure Japan Uterine Fibroids Market Size 2014-2019 (Million US$)
Table Japan Key Players Uterine Fibroids Revenue (2018-2019) (Million US$)
Table Japan Key Players Uterine Fibroids Market Share (2018-2019)
Table Japan Uterine Fibroids Market Size by Type (2014-2019) (Million US$)
Table Japan Uterine Fibroids Market Share by Type (2014-2019)
Table Japan Uterine Fibroids Market Size by Application (2014-2019) (Million US$)
Table Japan Uterine Fibroids Market Share by Application (2014-2019)
Figure Southeast Asia Uterine Fibroids Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Uterine Fibroids Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Uterine Fibroids Market Share (2018-2019)
Table Southeast Asia Uterine Fibroids Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Uterine Fibroids Market Share by Type (2014-2019)
Table Southeast Asia Uterine Fibroids Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Uterine Fibroids Market Share by Application (2014-2019)
Figure India Uterine Fibroids Market Size 2014-2019 (Million US$)
Table India Key Players Uterine Fibroids Revenue (2018-2019) (Million US$)
Table India Key Players Uterine Fibroids Market Share (2018-2019)
Table India Uterine Fibroids Market Size by Type (2014-2019) (Million US$)
Table India Uterine Fibroids Market Share by Type (2014-2019)
Table India Uterine Fibroids Market Size by Application (2014-2019) (Million US$)
Table India Uterine Fibroids Market Share by Application (2014-2019)
Figure Central & South America Uterine Fibroids Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Uterine Fibroids Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Uterine Fibroids Market Share (2018-2019)
Table Central & South America Uterine Fibroids Market Size by Type (2014-2019) (Million US$)
Table Central & South America Uterine Fibroids Market Share by Type (2014-2019)
Table Central & South America Uterine Fibroids Market Size by Application (2014-2019) (Million US$)
Table Central & South America Uterine Fibroids Market Share by Application (2014-2019)
Table Boston Scientific Company Details
Table Boston Scientific Revenue in Uterine Fibroids Business (2014-2019) (Million US$)
Figure Boston Scientific Revenue Growth Rate in Uterine Fibroids Business (2014-2019)
Table Boston Scientific Recent Development
Table Cooper Surgical Company Details
Table Cooper Surgical Revenue in Uterine Fibroids Business (2014-2019)(Million US$)
Figure Cooper Surgical Revenue Growth Rate in Uterine Fibroids Business (2014-2019)
Table Cooper Surgical Recent Development
Table C.R. Bard Company Details
Table C.R. Bard Revenue in Uterine Fibroids Business (2014-2019)(Million US$)
Figure C.R. Bard Revenue Growth Rate in Uterine Fibroids Business (2014-2019)
Table C.R. Bard Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Uterine Fibroids Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Uterine Fibroids Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table GE Healthcare Company Details
Table GE Healthcare Revenue in Uterine Fibroids Business (2014-2019)(Million US$)
Figure GE Healthcare Revenue Growth Rate in Uterine Fibroids Business (2014-2019)
Table GE Healthcare Recent Development
Table Karl Storz Endoscopy Company Details
Table Karl Storz Endoscopy Revenue in Uterine Fibroids Business (2014-2019)(Million US$)
Figure Karl Storz Endoscopy Revenue Growth Rate in Uterine Fibroids Business (2014-2019)
Table Karl Storz Endoscopy Recent Development
Table Richard Wolf Medical Instruments Company Details
Table Richard Wolf Medical Instruments Revenue in Uterine Fibroids Business (2014-2019)(Million US$)
Figure Richard Wolf Medical Instruments Revenue Growth Rate in Uterine Fibroids Business (2014-2019)
Table Richard Wolf Medical Instruments Recent Development
Table Siemens Medical Solutions Company Details
Table Siemens Medical Solutions Revenue in Uterine Fibroids Business (2014-2019)(Million US$)
Figure Siemens Medical Solutions Revenue Growth Rate in Uterine Fibroids Business (2014-2019)
Table Siemens Medical Solutions Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Uterine Fibroids Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Uterine Fibroids Business (2014-2019)
Table AbbVie Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Uterine Fibroids Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Uterine Fibroids Business (2014-2019)
Table AstraZeneca Recent Development
Table Bayer Company Details
Table Eli Lilly Company Details
Table GlaxoSmithKline Pharmaceuticals Company Details
Table Pfizer Company Details
Table Johnson & Johnson Company Details
Table Novartis Company Details
Table Global Uterine Fibroids Market Size by Regions (Million US$) 2019-2025
Figure Global Uterine Fibroids Market Size Share by Regions (2019-2025)
Figure Global Uterine Fibroids Market Size Share by Regions in 2025
Figure United States Uterine Fibroids Market Size Forecast (2019-2025)(Million USD)
Figure Europe Uterine Fibroids Market Size Forecast (2019-2025)(Million USD)
Figure China Uterine Fibroids Market Size Forecast (2019-2025)(Million USD)
Figure Japan Uterine Fibroids Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Uterine Fibroids Market Size Forecast (2019-2025)(Million USD)
Figure India Uterine Fibroids Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Uterine Fibroids Market Size Forecast (2019-2025)(Million USD)
Table Global Uterine Fibroids Market Size by Product (2019-2025) (Million US$)
Figure Global Uterine Fibroids Market Size by Product (2019-2025)
Figure Global Uterine Fibroids Market Size by Product in 2025
Table Global Uterine Fibroids Market Size by Application (2019-2025) (Million US$)
Figure Global Uterine Fibroids Market Size by Application (2019-2025)
Figure Global Uterine Fibroids Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Uterine Fibroids Market Size Growth Rate by Type (2014-2025)
1.4.2 Non-Hormonal Treatment
1.4.3 Hormonal Treatment
1.5 Market by Application
1.5.1 Global Uterine Fibroids Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Diagnostic Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Uterine Fibroids Market Size
2.2 Uterine Fibroids Growth Trends by Regions
2.2.1 Uterine Fibroids Market Size by Regions (2014-2025)
2.2.2 Uterine Fibroids Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Uterine Fibroids Market Size by Manufacturers
3.1.1 Global Uterine Fibroids Revenue by Manufacturers (2014-2019)
3.1.2 Global Uterine Fibroids Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Uterine Fibroids Market Concentration Ratio (CR5 and HHI)
3.2 Uterine Fibroids Key Players Head office and Area Served
3.3 Key Players Uterine Fibroids Product/Solution/Service
3.4 Date of Enter into Uterine Fibroids Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Uterine Fibroids Market Size by Type (2014-2019)
4.2 Global Uterine Fibroids Market Size by Application (2014-2019)
5 United States
5.1 United States Uterine Fibroids Market Size (2014-2019)
5.2 Uterine Fibroids Key Players in United States
5.3 United States Uterine Fibroids Market Size by Type
5.4 United States Uterine Fibroids Market Size by Application
6 Europe
6.1 Europe Uterine Fibroids Market Size (2014-2019)
6.2 Uterine Fibroids Key Players in Europe
6.3 Europe Uterine Fibroids Market Size by Type
6.4 Europe Uterine Fibroids Market Size by Application
7 China
7.1 China Uterine Fibroids Market Size (2014-2019)
7.2 Uterine Fibroids Key Players in China
7.3 China Uterine Fibroids Market Size by Type
7.4 China Uterine Fibroids Market Size by Application
8 Japan
8.1 Japan Uterine Fibroids Market Size (2014-2019)
8.2 Uterine Fibroids Key Players in Japan
8.3 Japan Uterine Fibroids Market Size by Type
8.4 Japan Uterine Fibroids Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Uterine Fibroids Market Size (2014-2019)
9.2 Uterine Fibroids Key Players in Southeast Asia
9.3 Southeast Asia Uterine Fibroids Market Size by Type
9.4 Southeast Asia Uterine Fibroids Market Size by Application
10 India
10.1 India Uterine Fibroids Market Size (2014-2019)
10.2 Uterine Fibroids Key Players in India
10.3 India Uterine Fibroids Market Size by Type
10.4 India Uterine Fibroids Market Size by Application
11 Central & South America
11.1 Central & South America Uterine Fibroids Market Size (2014-2019)
11.2 Uterine Fibroids Key Players in Central & South America
11.3 Central & South America Uterine Fibroids Market Size by Type
11.4 Central & South America Uterine Fibroids Market Size by Application
12 International Players Profiles
12.1 Boston Scientific
12.1.1 Boston Scientific Company Details
12.1.2 Company Description and Business Overview
12.1.3 Uterine Fibroids Introduction
12.1.4 Boston Scientific Revenue in Uterine Fibroids Business (2014-2019)
12.1.5 Boston Scientific Recent Development
12.2 Cooper Surgical
12.2.1 Cooper Surgical Company Details
12.2.2 Company Description and Business Overview
12.2.3 Uterine Fibroids Introduction
12.2.4 Cooper Surgical Revenue in Uterine Fibroids Business (2014-2019)
12.2.5 Cooper Surgical Recent Development
12.3 C.R. Bard
12.3.1 C.R. Bard Company Details
12.3.2 Company Description and Business Overview
12.3.3 Uterine Fibroids Introduction
12.3.4 C.R. Bard Revenue in Uterine Fibroids Business (2014-2019)
12.3.5 C.R. Bard Recent Development
12.4 F. Hoffmann-La Roche
12.4.1 F. Hoffmann-La Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Uterine Fibroids Introduction
12.4.4 F. Hoffmann-La Roche Revenue in Uterine Fibroids Business (2014-2019)
12.4.5 F. Hoffmann-La Roche Recent Development
12.5 GE Healthcare
12.5.1 GE Healthcare Company Details
12.5.2 Company Description and Business Overview
12.5.3 Uterine Fibroids Introduction
12.5.4 GE Healthcare Revenue in Uterine Fibroids Business (2014-2019)
12.5.5 GE Healthcare Recent Development
12.6 Karl Storz Endoscopy
12.6.1 Karl Storz Endoscopy Company Details
12.6.2 Company Description and Business Overview
12.6.3 Uterine Fibroids Introduction
12.6.4 Karl Storz Endoscopy Revenue in Uterine Fibroids Business (2014-2019)
12.6.5 Karl Storz Endoscopy Recent Development
12.7 Richard Wolf Medical Instruments
12.7.1 Richard Wolf Medical Instruments Company Details
12.7.2 Company Description and Business Overview
12.7.3 Uterine Fibroids Introduction
12.7.4 Richard Wolf Medical Instruments Revenue in Uterine Fibroids Business (2014-2019)
12.7.5 Richard Wolf Medical Instruments Recent Development
12.8 Siemens Medical Solutions
12.8.1 Siemens Medical Solutions Company Details
12.8.2 Company Description and Business Overview
12.8.3 Uterine Fibroids Introduction
12.8.4 Siemens Medical Solutions Revenue in Uterine Fibroids Business (2014-2019)
12.8.5 Siemens Medical Solutions Recent Development
12.9 AbbVie
12.9.1 AbbVie Company Details
12.9.2 Company Description and Business Overview
12.9.3 Uterine Fibroids Introduction
12.9.4 AbbVie Revenue in Uterine Fibroids Business (2014-2019)
12.9.5 AbbVie Recent Development
12.10 AstraZeneca
12.10.1 AstraZeneca Company Details
12.10.2 Company Description and Business Overview
12.10.3 Uterine Fibroids Introduction
12.10.4 AstraZeneca Revenue in Uterine Fibroids Business (2014-2019)
12.10.5 AstraZeneca Recent Development
12.11 Bayer
12.12 Eli Lilly
12.13 GlaxoSmithKline Pharmaceuticals
12.14 Pfizer
12.15 Johnson & Johnson
12.16 Novartis
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Uterine Fibroids Key Market Segments
Table Key Players Uterine Fibroids Covered
Table Global Uterine Fibroids Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Uterine Fibroids Market Size Market Share by Type 2014-2025
Figure Non-Hormonal Treatment Figures
Table Key Players of Non-Hormonal Treatment
Figure Hormonal Treatment Figures
Table Key Players of Hormonal Treatment
Table Global Uterine Fibroids Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Diagnostic Centers Case Studies
Figure Others Case Studies
Figure Uterine Fibroids Report Years Considered
Table Global Uterine Fibroids Market Size 2014-2025 (Million US$)
Figure Global Uterine Fibroids Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Uterine Fibroids Market Size by Regions 2014-2025 (Million US$)
Table Global Uterine Fibroids Market Size by Regions 2014-2019 (Million US$)
Table Global Uterine Fibroids Market Share by Regions 2014-2019
Figure Global Uterine Fibroids Market Share by Regions 2014-2019
Figure Global Uterine Fibroids Market Share by Regions 2019
Table Market Top Trends
Table Global Uterine Fibroids Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Uterine Fibroids Market Share by Manufacturers (2014-2019)
Figure Global Uterine Fibroids Market Share by Manufacturers in 2018
Table Global Uterine Fibroids Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Uterine Fibroids Product/Solution/Service
Table Date of Enter into Uterine Fibroids Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Uterine Fibroids Market Size by Type (2014-2019) (Million US$)
Table Global Uterine Fibroids Market Size Share by Type (2014-2019)
Figure Global Uterine Fibroids Market Size Market Share by Type (2014-2019)
Table Global Uterine Fibroids Market Size by Application (2014-2019) (Million US$)
Table Global Uterine Fibroids Market Size Share by Application (2014-2019)
Figure Global Uterine Fibroids Market Size Market Share by Application (2014-2019)
Figure Global Uterine Fibroids Revenue Market Share by Application in 2018
Figure United States Uterine Fibroids Market Size 2014-2019 (Million US$)
Table United States Key Players Uterine Fibroids Revenue (2018-2019) (Million US$)
Table United States Key Players Uterine Fibroids Market Share (2018-2019)
Table United States Uterine Fibroids Market Size by Type (2014-2019) (Million US$)
Table United States Uterine Fibroids Market Share by Type (2014-2019)
Table United States Uterine Fibroids Market Size by Application (2014-2019) (Million US$)
Table United States Uterine Fibroids Market Share by Application (2014-2019)
Figure Europe Uterine Fibroids Market Size 2014-2019 (Million US$)
Table Europe Key Players Uterine Fibroids Revenue (2018-2019) (Million US$)
Table Europe Key Players Uterine Fibroids Market Share (2018-2019)
Table Europe Uterine Fibroids Market Size by Type (2014-2019) (Million US$)
Table Europe Uterine Fibroids Market Share by Type (2014-2019)
Table Europe Uterine Fibroids Market Size by Application (2014-2019) (Million US$)
Table Europe Uterine Fibroids Market Share by Application (2014-2019)
Figure China Uterine Fibroids Market Size 2014-2019 (Million US$)
Table China Key Players Uterine Fibroids Revenue (2018-2019) (Million US$)
Table China Key Players Uterine Fibroids Market Share (2018-2019)
Table China Uterine Fibroids Market Size by Type (2014-20189) (Million US$)
Table China Uterine Fibroids Market Share by Type (2014-2019)
Table China Uterine Fibroids Market Size by Application (2014-2019) (Million US$)
Table China Uterine Fibroids Market Share by Application (2014-2019)
Figure Japan Uterine Fibroids Market Size 2014-2019 (Million US$)
Table Japan Key Players Uterine Fibroids Revenue (2018-2019) (Million US$)
Table Japan Key Players Uterine Fibroids Market Share (2018-2019)
Table Japan Uterine Fibroids Market Size by Type (2014-2019) (Million US$)
Table Japan Uterine Fibroids Market Share by Type (2014-2019)
Table Japan Uterine Fibroids Market Size by Application (2014-2019) (Million US$)
Table Japan Uterine Fibroids Market Share by Application (2014-2019)
Figure Southeast Asia Uterine Fibroids Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Uterine Fibroids Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Uterine Fibroids Market Share (2018-2019)
Table Southeast Asia Uterine Fibroids Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Uterine Fibroids Market Share by Type (2014-2019)
Table Southeast Asia Uterine Fibroids Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Uterine Fibroids Market Share by Application (2014-2019)
Figure India Uterine Fibroids Market Size 2014-2019 (Million US$)
Table India Key Players Uterine Fibroids Revenue (2018-2019) (Million US$)
Table India Key Players Uterine Fibroids Market Share (2018-2019)
Table India Uterine Fibroids Market Size by Type (2014-2019) (Million US$)
Table India Uterine Fibroids Market Share by Type (2014-2019)
Table India Uterine Fibroids Market Size by Application (2014-2019) (Million US$)
Table India Uterine Fibroids Market Share by Application (2014-2019)
Figure Central & South America Uterine Fibroids Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Uterine Fibroids Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Uterine Fibroids Market Share (2018-2019)
Table Central & South America Uterine Fibroids Market Size by Type (2014-2019) (Million US$)
Table Central & South America Uterine Fibroids Market Share by Type (2014-2019)
Table Central & South America Uterine Fibroids Market Size by Application (2014-2019) (Million US$)
Table Central & South America Uterine Fibroids Market Share by Application (2014-2019)
Table Boston Scientific Company Details
Table Boston Scientific Revenue in Uterine Fibroids Business (2014-2019) (Million US$)
Figure Boston Scientific Revenue Growth Rate in Uterine Fibroids Business (2014-2019)
Table Boston Scientific Recent Development
Table Cooper Surgical Company Details
Table Cooper Surgical Revenue in Uterine Fibroids Business (2014-2019)(Million US$)
Figure Cooper Surgical Revenue Growth Rate in Uterine Fibroids Business (2014-2019)
Table Cooper Surgical Recent Development
Table C.R. Bard Company Details
Table C.R. Bard Revenue in Uterine Fibroids Business (2014-2019)(Million US$)
Figure C.R. Bard Revenue Growth Rate in Uterine Fibroids Business (2014-2019)
Table C.R. Bard Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Uterine Fibroids Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Uterine Fibroids Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table GE Healthcare Company Details
Table GE Healthcare Revenue in Uterine Fibroids Business (2014-2019)(Million US$)
Figure GE Healthcare Revenue Growth Rate in Uterine Fibroids Business (2014-2019)
Table GE Healthcare Recent Development
Table Karl Storz Endoscopy Company Details
Table Karl Storz Endoscopy Revenue in Uterine Fibroids Business (2014-2019)(Million US$)
Figure Karl Storz Endoscopy Revenue Growth Rate in Uterine Fibroids Business (2014-2019)
Table Karl Storz Endoscopy Recent Development
Table Richard Wolf Medical Instruments Company Details
Table Richard Wolf Medical Instruments Revenue in Uterine Fibroids Business (2014-2019)(Million US$)
Figure Richard Wolf Medical Instruments Revenue Growth Rate in Uterine Fibroids Business (2014-2019)
Table Richard Wolf Medical Instruments Recent Development
Table Siemens Medical Solutions Company Details
Table Siemens Medical Solutions Revenue in Uterine Fibroids Business (2014-2019)(Million US$)
Figure Siemens Medical Solutions Revenue Growth Rate in Uterine Fibroids Business (2014-2019)
Table Siemens Medical Solutions Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Uterine Fibroids Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Uterine Fibroids Business (2014-2019)
Table AbbVie Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Uterine Fibroids Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Uterine Fibroids Business (2014-2019)
Table AstraZeneca Recent Development
Table Bayer Company Details
Table Eli Lilly Company Details
Table GlaxoSmithKline Pharmaceuticals Company Details
Table Pfizer Company Details
Table Johnson & Johnson Company Details
Table Novartis Company Details
Table Global Uterine Fibroids Market Size by Regions (Million US$) 2019-2025
Figure Global Uterine Fibroids Market Size Share by Regions (2019-2025)
Figure Global Uterine Fibroids Market Size Share by Regions in 2025
Figure United States Uterine Fibroids Market Size Forecast (2019-2025)(Million USD)
Figure Europe Uterine Fibroids Market Size Forecast (2019-2025)(Million USD)
Figure China Uterine Fibroids Market Size Forecast (2019-2025)(Million USD)
Figure Japan Uterine Fibroids Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Uterine Fibroids Market Size Forecast (2019-2025)(Million USD)
Figure India Uterine Fibroids Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Uterine Fibroids Market Size Forecast (2019-2025)(Million USD)
Table Global Uterine Fibroids Market Size by Product (2019-2025) (Million US$)
Figure Global Uterine Fibroids Market Size by Product (2019-2025)
Figure Global Uterine Fibroids Market Size by Product in 2025
Table Global Uterine Fibroids Market Size by Application (2019-2025) (Million US$)
Figure Global Uterine Fibroids Market Size by Application (2019-2025)
Figure Global Uterine Fibroids Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
RESEARCH METHODOLOGY
A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.
Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.
Now let’s take a closer look at the research methods here.
Secondary Research Model
Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.
Primary Insights
Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.
However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.
Market Estimation
The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.
Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.
Final Presentation
The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.
You can also purchase parts of this report. Do you want to check out a section wise price list?
Personalized Business Report Tailored to Your Requirements
- Our expert analysts collaborate directly with you to comprehend your specific needs.
- Get data on regions, segments, competitors, and vendors of your choice.
- Information is presented in alignment with your exact preferences and formatting.
Free Sample Report
"Find new revenue generation opportunities"